POZ September 2025
POZ September 2025
In every issue of POZ, you’ll find the latest health news, personal stories and much more.
Also Available On:
Features
The Art of Living in the Present
An HIV long-term survivor reflects on joining the 50-and-over club.
It’s Not Just Grief
Acknowledging anger during these trying times is vital to facing the challenges ahead.
To Stay Positive, Embrace the Negative
We must process what is lost to welcome what is next.
Editor’s Letter
In My Life
Aging warps time for us all, but living with HIV as we get older adds even more wrinkles to the process.
POZ Q&A
Listening to Uplift
A new podcast explores what it means to be a “church with AIDS.”
POZ Planet
CDC Upheaval Disrupts HIV Surveys
Researchers were laid off before completing their projects.
Training HIV Long-Term Survivors
A new leadership academy launches.
New Indianapolis HIV Wellness Headquarters
The Damien Center expands its supportive services.
Maryland Repeals HIV Crime Law
It’s the fifth state to repeal such laws.
Everyday – September 2025
These dates represent milestones in the HIV epidemic. Visit poz.com/aidsiseveryday to learn more about the history of HIV and AIDS.
Voices
Stigma Persists
Long-term survivor and former New York State Senator Tom Duane is struck by the misconception that HIV stigma is vastly diminished.
Starving for Knowledge
An opinion piece titled “The U.S. Government Is Starving Its Own Scientists of Knowledge” argues for transparency. Read an edited excerpt.
Spotlight
Trans Mobilization
National Trans Visibility March participants said it’s important for the trans community to come together at this time.
Basics
Exercise and HIV
Getting enough physical activity is an important part of a healthy lifestyle.
Research Notes
Prevention: PrEP for Youth
More can be done to boost access to PrEP.
Treatment: New Meds on Hold
Two studies were paused after some people receiving both drugs had decreases in their CD4 T-cell or absolute lymphocyte count.
Cure: mRNA Unmasks HIV
A team in Australia hypothesized that mRNA encoding proteins that reverse HIV latency could help flush out the virus.
Concerns: Anal Cancer
The Food and Drug Administration approved Zynyz (retifanlimab), the first immunotherapy for people with advanced anal cancer.
Care & Treatment
FDA Approves Twice-Yearly Lenacapavir PrEP
The approval is supported by two large studies showing that lenacapavir dramatically reduced the risk of HIV acquisition.
Next Steps Toward an HIV Vaccine
Current findings are promising, but they are just early steps in a long process.
Supreme Court Decisions Could Affect HIV Services
Around 40% of people living with HIV rely on Medicaid.
Cancer Rates Among People With HIV
Rates of most types of cancer are falling or stable among people living with HIV.
Heroes
Reaching the Summit
Michael Maus has been advocating for HIV services in Oklahoma for more than 25 years.
Survey
Aging With HIV
Take our survey and let POZ know how you’re aging with HIV.
Digital Edition
POZ September 2025
Read the digital edition.
